Role of dual antiplatelet therapy in symptomatic patients with established vascular disease:putting the CHARISMA trial into therapeutic perspective

Boden, William E, Flather, Marcus D and Bhatt, Deepak L (2010) Role of dual antiplatelet therapy in symptomatic patients with established vascular disease:putting the CHARISMA trial into therapeutic perspective. Cardiovascular Drugs and Therapy, 24 (3). pp. 207-16. ISSN 1573-7241

Full text not available from this repository. (Request a copy)

Abstract

The CHARISMA (Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance) trial has spurred debate over subgroup analysis interpretation and prompted renewed consideration of the long-term role of dual aspirin and clopidogrel therapy (DAPT) in patients with established vascular disease.

Item Type: Article
Uncontrolled Keywords: aspirin,hemorrhage,humans,platelet aggregation inhibitors,randomized controlled trials as topic,retrospective studies,risk,thrombosis,ticlopidine,time factors,vascular diseases
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 20 Jan 2014 16:12
Last Modified: 21 Apr 2020 22:33
URI: https://ueaeprints.uea.ac.uk/id/eprint/46250
DOI: 10.1007/s10557-010-6245-9

Actions (login required)

View Item View Item